NONSTEROID ANTI-INFLAMMATORY DRUGS FOR THE TREATEMENT OF OSTEOARTHROSIS: COMPARATIVE EFFICACY AND TOLERABILITY OF NIMESULIDE
https://doi.org/10.21518/2079-701X-2018-1-80-85
Abstract
Nonsteroid anti-inflammatory drugs are the fast-acting medications used widely to treat pain and inflammation for osteoarthritis. The pharmacological activity of most of them is characterized by the chondronegative action on osteoarthrosis cartilage, which manifests itself as inhibition of the chondrocyte metabolic activity and intensification of its apoptosis, which reduces the synthesis of proteoglycans, the main intercellular substance of the hyaline cartilage and thus its degeneration rates. In contrast, nimesulides show a chondronegative action. The article presents the results of a comparative randomized study evaluating the efficacy and tolerability of two Nimesulide generics, Nimesan and Nise. Nimesan was not only inferior to Nise by its characteristics, but also proved to be more efficient by the overall WOMAC index, positive dynamics of the functional capacity of the affected joints and the ESR index. Both drugs showed comparable tolerability and safety results.
About the Author
V. V. Badokin
Russian Medical Academy of Continuing Postgraduate Education of the Ministry of Health of Russia, Moscow
Russian Federation
MD, Prof
Russian Federation
MD, Prof
References
1. Reid JL, Morton DJ, Wingard DD et al. Obesity and other cardiovascular disease risk factors and their association with osteoarthritis in Southern California American Indians, 2002–2006. Ethn. Dis., 2010, 20(4): 416–22.
2. Van den Berg W.B. Pathophysiology of osteoarthritis. Joint Bone Spine, 2000, 67(6): 555–56.
3. Martel-Pelletier J, Pelletier J-P. Inflammatory factors involved in osteoarthritis. Osteoarthritis, Inflammation and Degradation: A Continuum. Eds. JA Buckwalter, M Lotz, J-F Stoltz. IOS Press. 2007.
4. Zhang W, Moskowitz RW, Nuki G et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cart, 2008, 16(2): 137–162.
5. Насонов Е.Л. Перспективы применения нового нестероидного противовоспалительного препарата нимесулид. Клиническая фармакология и терапия, 1999, 1: 65–9.
6. Kullich WC, Niksic F, Klein G. Effect of nimesulide on metalloproteinas-es and matrix degradation in osteoarthritis: a pilot clinical study. Int. J. Clin. Pract., 2002, Suppl. 128: 24–29.
7. Каратеев А.Е. Нимесулид: вопросы безопасности и возможность длительного применения. Фарматека, 2009, 4: 17–25.
8. Kriegel W, Korff KJ, Ehrlich JC et al. Double-blind study comparing the long-term efficacy of the COX-2 inhibitor nimesulide and naproxen in patients with osteoarthritis. Int. J. Clin. Pract., 2001, 55(8): 510–14.
9. Conforti A, Leone R, Moretti U et al. Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide: results of spontaneous reporting from a Northern Italian area. Drug Saf, 2001, 24(14): 1081–90.
10. Bruyère O, Cooper C, Pelletier JP et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin. Arthritis Rheum., 2014, 44(3): 253-63.
Review
For citations:
Badokin VV. NONSTEROID ANTI-INFLAMMATORY DRUGS FOR THE TREATEMENT OF OSTEOARTHROSIS: COMPARATIVE EFFICACY AND TOLERABILITY OF NIMESULIDE. Meditsinskiy sovet = Medical Council. 2018;(1):80-85. (In Russ.) https://doi.org/10.21518/2079-701X-2018-1-80-85
Views:
1195
Email this article 